Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants - Milestone Pharmaceuticals (NASDAQ:MIST)
MONTREAL and CHARLOTTE, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. ("Milestone") (NASDAQ:MIST), a biopharmaceutical company focused on the development and commercialization of